Your Search Returned 127 tagged news reports
New rules needed to weed out Big Pharma's unethical 'seeding studies,' says U bioethicist Published Tue, Aug 2 2011 8:27 am In July, the federal government proposed new rules governing the protection of human participants in medical studies. But as
two of the largest generic-drug makers, released solid earnings this week...The way the generic-drug system works in the U.S., the first generic-drug maker to challenge a patent on a brand-name drug is granted a six-month exclusivity period.
Jul 23, 2011 After being silent for more than six years, two women who say their doctor-husbands died from undisclosed Neurontin risks have decided to speak out. What began as something deeply personal and private in their lives has become their call
In April 2009, I woke up one morning with a swelling in my left jaw and cheek. My family doctor suggested I go to the local dentist, who said it acted like temporomandibular joint (TMJ) disorder but he doubted it, so he gave me some Diflunisal...Then
On Tuesdays, it's Dr. Charles Raison , an associate professor of psychiatry and behavioral sciences at Emory University, and an expert in the mind-body connection for health...I find it hard to concentrate and my limited mobility makes everything
The true purpose of a drug trial is not always obvious Medical trials are not always conducted to test the drug sometimes it's to test the market "Seeding trials" are carried out to promote the use of new drugs Here's a fun new way to distort science
About this Author Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical
A postmarketing study of the epilepsy drug gabapentin (Neurontin) sponsored by its manufacturer was intended mainly to turn its hundreds of clinician-investigators into enthusiasts for the product.
The test was allegedly designed to document how various doses could treat epilepsy . But it turns out the trial was set up to "seed" the results in order to sell the drug, much like a card shark might stack a deck of cards in order to cheat at a game
A 1995 study that was ostensibly designed to assess the safety, efficacy, tolerability and quality of life among Neurontin patients was actually a thinly disguised seeding trial, according to an article in The Annals of Internal Medicine...The last